Posted Apr 3, 2023, 10:27 AM
This is one of the biggest increases in the Paris Stock Exchange on Monday. Innate Pharma rose by more than 15% to cross the 3 euro mark, in reaction to the announcement of a new exclusive license granted within the framework of the research and development of conjugated antibodies which will be used in the treatment of celiac disease.
Celiac disease, which results in particular in gluten intolerance, is a chronic and autoimmune intestinal disease linked to the ingestion of gluten, formed from gliadin which is found, for example, in certain cereal products (wheat , barley, rye). It occurs in genetically predisposed people. Ultimately, this can cause damage to the inner wall of the intestine (atrophy of the villi of the intestinal mucosa), with two consequences, impaired digestion and less good assimilation of a large part of the nutrients (proteins, fats…), minerals and vitamins (iron, calcium, vitamin D, vitamin B9 or folic acid…).
